• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 57 of 100
Fosun International Ltd. Chairman And Billionaire Guo Guangchang Attends Interim Results News Conference
FinanceChina’s Fosun Is Defying Beijing’s Crackdown on Debt and Foreign M&A
By Fortune Editors and ReutersAugust 14, 2017
Forbes Under 30 Summit
HealthWhy SoftBank Made a Record-Breaking $1.1 Billion Bet on This Biotech Firm
By Sy MukherjeeAugust 9, 2017
Why Martin Shkreli Won’t Be the Last Pharma Bro
CommentaryWhy Martin Shkreli Won’t Be the Last Pharma Bro
By Josh HoxieAugust 8, 2017
Hepatitis C drug can cure, if patients can get it
HealthThe FDA Just Approved the First Drug That Can Treat All Hepatitis C Strains in Just 8 Weeks
By Sy MukherjeeAugust 3, 2017
Inside Teva Pharmaceuticals Headquarters
FinancePharma Giant Teva’s Stock Is Imploding As Generic Drugs Get Cheaper
By BloombergAugust 3, 2017
Jury Deliberations Continue In Martin Shkreli Securities Fraud Trial
FinanceJury in Martin Shkreli Trial Asks the Judge to Define ‘Fraudulent Intent’
By ReutersAugust 1, 2017
World Science Festival
HealthWhat You Should Know About ALS, The Disease That Killed Actor and Playwright Sam Shepard
By Sy MukherjeeJuly 31, 2017
Former Turing Pharmaceuticals CEO Martin Shkreli Case Nears End As Lawyers Prepare For Final Argument
FinanceJury to Soon Begin Deliberations in ‘Pharma Bro’ Martin Shkreli’s Fraud Trial
By ReutersJuly 28, 2017
A sign is seen at an AstraZeneca site in Macclesfield
HealthHere’s Why Shares in This Former Pfizer Target Are Tanking
By Fortune Editors and ReutersJuly 27, 2017
Close up of blister packs red pills
Mitsubishi Tanabe Pharma Is Buying Neuroderm in a $1.1 Billion Bid to Expand Its U.S. Business
By ReutersJuly 24, 2017
Cystic fibrosis drug campaign
HealthThis Biotech Just Gained Billions in Market Value Thanks to Its Cystic Fibrosis Drug Cocktail
By Sy MukherjeeJuly 19, 2017
FDA Panel Backs Groundbreaking Novartis Treatment That Turns Your Cells Into Cancer Killers
HealthFDA Panel Backs Groundbreaking Novartis Treatment That Turns Your Cells Into Cancer Killers
By Sy MukherjeeJuly 12, 2017
Sickle Cell Anemia SEM
HealthThe FDA Approved the First New Sickle Cell Drug in 20 Years…But It’s Not a Cure
By Sy MukherjeeJuly 10, 2017
Neisseria Gonorrhoeae
Health‘Smart’ Gonorrhea Is the Latest Threat In a Troubling Superbug Trend
By Sy MukherjeeJuly 8, 2017
View of stethoscope on table in laboratory
HealthDrug and Device Makers Shelled Out $8 Billion to Doctors and Hospitals Last Year
By Sy MukherjeeJuly 6, 2017
1...
  • 55
  • 56
  • 57
  • 58
  • 59
...100
Most Popular
Politics
'This is the last warning.' Iran threatens U.S. warships after they throw down the gauntlet for winner-take-all Strait of Hormuzplaceholder alt text
By Fortune EditorsApril 11, 2026
Real Estate
A 93-year-old refused to sell her home to the Masters golf course that’s spent $280 million on expansion: ‘Money ain’t everything’placeholder alt text
By Fortune EditorsApril 12, 2026
Economy
'People are trying to be creative': Tariff-battered American companies are so cash-starved they are using refund claims as collateral for loansplaceholder alt text
By Fortune EditorsApril 12, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.